← All Dyne Therapeutics, INC filings

Dyne Therapeutics, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
DYN
Dyne Therapeutics, INC
DEFA14A: Dyne Therapeutics Files Definitive Proxy Statement with SEC
Dyne Therapeutics has filed a definitive proxy statement with the Securities and Exchange Commission.
NASDAQ
DYN
Dyne Therapeutics, INC
DEF: Dyne Therapeutics Sets Date for 2025 Annual Stockholders Meeting, Outlines Key Proposals
Dyne Therapeutics announces its 2025 Annual Meeting of Stockholders to be held virtually on May 30, 2025, featuring director elections, executive compensation votes, and auditor ratification.
NASDAQ
DYN
Dyne Therapeutics, INC
DEFA14A: Dyne Therapeutics Files Definitive Proxy Statement with SEC
Dyne Therapeutics has filed a definitive proxy statement with the Securities and Exchange Commission.
NASDAQ
DYN
Dyne Therapeutics, INC
DEF 14A: Dyne Therapeutics Sets Date for 2024 Annual Stockholders Meeting, Outlines Key Proposals
Dyne Therapeutics will hold its 2024 Annual Meeting of Stockholders virtually on May 22, 2024, to vote on director elections and the ratification of its accounting firm.